Tesarakt

AI for a truly intelligent health system

New York, United States · Founded 2022 · $250K raised

Headquarters
New York, New York
Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$250K
Last Round
$250K SeedJul 2024
Rounds
1

About

Tesarakt is a Columbia University spin-off developing predictive AI for neurological disease diagnosis. Using machine learning applied to conventional MRI scans and the largest available MRI database, the platform detects Parkinson's and Alzheimer's disease years before first symptoms appear. The company was founded in 2022 and participated in IndieBio NYC Class 4.

Summary

Tesarakt is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $250K in total across 1 round, most recently a $250K Seed round in Jul 2024. Investors include IndieBio, SOSV and Ferocity Capital.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJul 2024
$250K

Investors

Similar Companies